Currently, Merck & Company, Inc. (NYSE:MRK) shares have a consensus target price of $68.384. The covering Wall Street analyst giving the highest target price according to data provided by Zacks Research, is presently $80. The analyst providing the lowest target on the stock estimates shares going to $59.
Depending on the analyst, target price projections may vary. Street analysts may look at stock price resistance and support levels to help evaluate where the stock could be headed in the future. Zacks Research also provides ratings from covering sell-side analysts. These recommendations fall on a scale provided by Zacks Research. Based on ratings from polled analysts, Zacks Research notes shares of Merck & Company, Inc. with a current ABR of 1.86. This number is set on a recommendation scale where the ratings range between a 1 and a 5. On the scale, a 1 would indicate a Strong Buy rating while a 5 would represent a Strong Sell.
We can also take a look at some company earnings per share or EPS information. Earnings per share is the segment of profit for a company that is allocated to every outstanding share of a company’s common stock. Earnings per share numbers can serve as an indicator for the profitability of a certain company. EPS is widely considered to be one of the most important factors when evaluating the price of a share. A Zacks consensus currently shows Street analysts projecting the company to post per share earnings of $0.9. For the period ending 2016-09-30, Merck & Company, Inc. reported actual EPS of $1.07. This number was $0.09 away from analyst predictions, providing a surprise factor of 9.18%. The company is expected to next release earnings on or around 2017-02-02.